MoneyWorks4Me

Gufic Biosciences - Quaterly Results

30 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 2050.20 millions grew by 5.14 % from Rs. 1949.94 millions.The Net Profit of the company slipped to Rs. 79.75 millions from Rs. 200.47 millions, a decline of -60.22% on QoQ basis.A decline of 270.23 millions was observed in the OP in the quarter ended March 2025 from 351.09 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2050.20 1949.94 5.14 8198.06 8066.66 1.63 8198.06 8066.66 1.63
Other Income 3.83 8.81 -56.53 36.15 21.77 66.05 36.15 21.77 66.05
PBIDT 270.23 351.09 -23.03 1386.03 1480.48 -6.38 1386.03 1480.48 -6.38
Interest 84.00 36.47 130.33 231.12 153.60 50.47 231.12 153.60 50.47
PBDT 186.23 314.62 -40.81 1154.91 1326.88 -12.96 1154.91 1326.88 -12.96
Depreciation 78.43 43.42 80.63 210.64 170.17 23.78 210.64 170.17 23.78
PBT 107.80 271.20 -60.25 944.27 1156.71 -18.37 944.27 1156.71 -18.37
TAX 28.05 70.73 -60.34 244.95 295.36 -17.07 244.95 295.36 -17.07
Deferred Tax 25.12 -2.27 -1206.61 57.51 31.65 81.71 57.51 31.65 81.71
PAT 79.75 200.47 -60.22 699.32 861.35 -18.81 699.32 861.35 -18.81
Equity 100.28 100.28 0.00 100.28 100.28 0.00 100.28 100.28 0.00
PBIDTM(%) 13.18 18.01 -26.80 16.91 18.35 -7.88 16.91 18.35 -7.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..